74320891
Oct 8, 1992
therapeutic agents for the treatment of in vivo oxidative damage resulting from and/or causing conditions such as reperfusion injury, hepatic disease, adult respiratory distress syndrome, immune disorders, latent viral infections, atherosclerosis, acquired immune deficiency syndrome, inflammatory response, chronic infections, pulmonary disease, diabetic complications, psoriasis, antiretroviral therapy, chemotherapy, radiation therapy, aging, as well as agents for treating infertility and the prevention of hair loss and stimulation of hair growth
Pharmaceuticals